Table: Jcr Pharmaceuticals - 9-MTH group results

JCR Pharmaceuticals

26/01/2024 07:00

Jan 26 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               33.72               26.70            45.40    
                   (+26.3 pct)         (-33.7 pct)      (+32.2 pct) 
  Operating            7.81                4.95            10.50    
                   (+57.7 pct)         (-73.0 pct)     (+111.0 pct) 
  Recurring            7.39                5.29            10.00    
                   (+39.6 pct)         (-71.7 pct)      (+84.6 pct) 
  Net                  5.16                3.57             7.30    
                   (+44.6 pct)         (-72.4 pct)      (+93.5 pct) 
  EPS               41.35 yen           28.73 yen        58.71 yen  
  EPS Diluted       41.16 yen           28.61 yen                   
  Ann Div                               20.00 yen        20.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T